Stock CYTO ALTAMIRA THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Altamira Therapeutics Ltd.

Equities

CYTO

BMG0360L1349

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
1.49 USD +0.68% Intraday chart for Altamira Therapeutics Ltd. +0.68% -57.18%
May. 16 Altamira Therapeutics Ltd. Elects Dominik Lysek as Member of Board of Directors CI
May. 01 Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. Revisions Altamira Therapeutics Ltd.